RAB5A, overexpressed in hepatocellular carcinomas, seems to be determinant for liver cancer progression, as suggested by the finding that a dominant negative form of RAB5A attenuates EGF-mediated signalling and cell migration of a human hepatoma cell line [8]. Here, RAB5A is linked to liver cancer.